Meeting Banner
Abstract #2996

Imaging treatment efficacy of repeated photodynamic therapy in glioblastoma using CEST MRI

Vivian W.M. Leung1, Joseph H.C. Lai1, Zilin Chen1, Jianpan Huang1, Se Weon Park1,2, Yang Liu1,2, Charles Hu3, and Kannie W. Y. Chan1,2,4,5,6
1Department of Biomedical Engineering, City University of Hong Kong, Hong Kong, China, 2Hong Kong Centre for Cerebro-Cardiovascular Health Engineering (COCHE), Hong Kong, China, 3Incando Therapeutics Pte Ltd, Singapore, Singapore, 4Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, United States, 5City University of Hong Kong Shenzhen Research Institute, Shenzhen, China, 6Tung Biomedical Sciences Centre, City University of Hong Kong, Hong Kong, China

Synopsis

Keywords: CEST & MT, Tumor

Glioblastoma (GBM) is hard to treat and has poor prognosis. Photodynamic therapy (PDT) is a promising treatment for GBM. Here, we detect the treatment efficacies of different PDT schemes (repeated (re-) and single (s-) PDT) on a rodent model of GBM using CEST MRI to monitor the molecular changes associated with tumor physiology and necrosis. Significant decreases in APT and rNOE signals were detected in the rePDT group as well as decreased proliferative activities in histology when compared with sPDT. This indicates that both APT and rNOE can be a reliable approach to assess PDT treatment efficacy against GBM.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords